Pascal Pillet

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Pierre Quartier, Florence Allantaz, Rolando Cimaz et al. · Annals of the Rheumatic Diseases · 2010 · 549 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

Pierre Quartier, Pierre Taupin, Franck Bourdeaut et al. · Arthritis & Rheumatism · 2003 · 368 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

Adriana A. de Jesus, Yangfeng Hou, Stephen R. Brooks et al. · Journal of Clinical Investigation · 2019 · 239 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients

Michaël Hofer, Pascal Pillet, M. Cochard et al. · Lara D. Veeken · 2014 · 200 citations · Full text

Medicine, Pediatrics, Cervical Disease +6

Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients

Dominique P. Germain, Alain Fouilhoux, Stéphane Decramer et al. · Clinical Genetics · 2019 · 164 citations · Full text

Medicine, Child Health, Pediatrics +12